These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 22113756

  • 1. Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway.
    Chen JJ, Zhou SH.
    Cardiol J; 2011; 18(6):675-81. PubMed ID: 22113756
    [Abstract] [Full Text] [Related]

  • 2. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS, Shen ZY, Ye WX, Huang HY, Hua F, Chen YH, Chen K, Lao WJ, Tao L.
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [Abstract] [Full Text] [Related]

  • 3. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
    Huang F, Zhu X, Hu XQ, Fang ZF, Tang L, Lu XL, Zhou SH.
    Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of MicroRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction.
    Huang F, Li ML, Fang ZF, Hu XQ, Liu QM, Liu ZJ, Tang L, Zhao YS, Zhou SH.
    Cardiology; 2013 Feb; 125(1):18-30. PubMed ID: 23615185
    [Abstract] [Full Text] [Related]

  • 5. [Effects of myocardial transplantation of mesenchymal stem cells transfected with vascular endothelial factor gene on improvement of heart function and angiogenesis after myocardial infarction: experiment with rats].
    Yang JF, Zhou WW, Tang T, Yu JF, Zhou XM, Hu JG.
    Zhonghua Yi Xue Za Zhi; 2006 Apr 18; 86(15):1027-34. PubMed ID: 16784704
    [Abstract] [Full Text] [Related]

  • 6. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.
    Yang J, Zhou W, Zheng W, Ma Y, Lin L, Tang T, Liu J, Yu J, Zhou X, Hu J.
    Cardiology; 2007 Apr 18; 107(1):17-29. PubMed ID: 16741354
    [Abstract] [Full Text] [Related]

  • 7. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.
    Huang J, Zhang Z, Guo J, Ni A, Deb A, Zhang L, Mirotsou M, Pratt RE, Dzau VJ.
    Circ Res; 2010 Jun 11; 106(11):1753-62. PubMed ID: 20378860
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart.
    Dakhlallah D, Zhang J, Yu L, Marsh CB, Angelos MG, Khan M.
    J Cardiovasc Pharmacol; 2015 Mar 11; 65(3):241-51. PubMed ID: 25658461
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.
    Chen Y, Zhao Y, Chen W, Xie L, Zhao ZA, Yang J, Chen Y, Lei W, Shen Z.
    Stem Cell Res Ther; 2017 Nov 25; 8(1):268. PubMed ID: 29178928
    [Abstract] [Full Text] [Related]

  • 12. Rosuvastatin treatment activates JAK-STAT pathway and increases efficacy of allogeneic mesenchymal stem cell transplantation in infarcted hearts.
    Xu H, Yang YJ, Qian HY, Tang YD, Wang H, Zhang Q.
    Circ J; 2011 Nov 25; 75(6):1476-85. PubMed ID: 21502705
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart.
    Glass C, Singla DK.
    Am J Physiol Heart Circ Physiol; 2011 Nov 25; 301(5):H2038-49. PubMed ID: 21856911
    [Abstract] [Full Text] [Related]

  • 14. Epac-Rap1-activated mesenchymal stem cells improve cardiac function in rat model of myocardial infarction.
    Khan I, Ali A, Akhter MA, Naeem N, Chotani MA, Iqbal H, Kabir N, Atiq M, Salim A.
    Cardiovasc Ther; 2017 Apr 25; 35(2):. PubMed ID: 28039940
    [Abstract] [Full Text] [Related]

  • 15. Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats.
    Xie X, Sun A, Zhu W, Huang Z, Hu X, Jia J, Zou Y, Ge J.
    Tohoku J Exp Med; 2012 Jan 25; 226(1):29-36. PubMed ID: 22186034
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of interleukin-7 in fusion of rat bone marrow mesenchymal stem cells with cardiomyocytes in vitro and improvement of cardiac function in vivo.
    Haneef K, Ali A, Khan I, Naeem N, Jamall S, Salim A.
    Cardiovasc Ther; 2018 Dec 25; 36(6):e12479. PubMed ID: 30451388
    [Abstract] [Full Text] [Related]

  • 19. Transplantation of telomerase/myocardin-co-expressing mesenchymal cells in the mouse promotes myocardial revascularization and tissue repair.
    Madonna R, Pieragostino D, Rossi C, Guarnieri S, Nagy CT, Giricz Z, Ferdinandy P, Del Boccio P, Mariggiò MA, Geng YJ, De Caterina R.
    Vascul Pharmacol; 2020 Dec 25; 135():106807. PubMed ID: 33130246
    [Abstract] [Full Text] [Related]

  • 20. Mesenchymal stem cells modified with angiopoietin-1 improve remodeling in a rat model of acute myocardial infarction.
    Sun L, Cui M, Wang Z, Feng X, Mao J, Chen P, Kangtao M, Chen F, Zhou C.
    Biochem Biophys Res Commun; 2007 Jun 08; 357(3):779-84. PubMed ID: 17445769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.